| Literature DB >> 27019050 |
Ying Sun1, Weici Zhang2, Jilly F Evans3, Annarosa Floreani4, Zhengsheng Zou5, Yukiko Nishio6, Ruizhao Qi7, Patrick S C Leung8, Christopher L Bowlus9, M Eric Gershwin10.
Abstract
Autotaxin (ATX) is a 125-kD type II ectonucleotide pyrophosphatase/phosphodiesterase (ENPP2 or NPP2) originally discovered as an unknown "autocrine motility factor" in human melanoma cells. In addition to its pyrophosphatase/phosphodiesterase activities ATX has lysophospholipase D (lysoPLD) activity, catalyzing the conversion of lysophosphatidylcholine (LPC) into lysophosphatidic acid (LPA). ATX is the only ENPP family member with lysoPLD activity and it produces most of the LPA in circulation. In support of this, ATX heterozygous mice have 50% of normal LPA plasma levels. The ATX-LPA signaling axis plays an important role in both normal physiology and disease pathogenesis and recently has been linked to pruritus in chronic cholestatic liver diseases, including primary biliary cholangitis (PBC). Several lines of evidence have suggested that a circulating puritogen is responsible, but the identification of the molecule has yet to be definitively identified. In contrast, plasma ATX activity is strongly associated with pruritus in PBC, suggesting a targetable molecule for treatment. We review herein the biochemistry of ATX and the rationale for its role in pruritus.Entities:
Keywords: Autotaxin; autoimmunity; cholestatic liver diseases; lysophosphatidylcholine; pruritus
Mesh:
Substances:
Year: 2016 PMID: 27019050 DOI: 10.1016/j.autrev.2016.03.019
Source DB: PubMed Journal: Autoimmun Rev ISSN: 1568-9972 Impact factor: 9.754